Integrated BioTherapeutics

About:

Integrated BioTherapeutics focuses on the discovery of novel vaccines and therapeutics for emerging infectious diseases.

Website: http://www.integratedbiotherapeutics.com

Top Investors: Wellcome Trust, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bill & Melinda Gates Foundation, Biomedical Advanced Research and Development Authority (BARDA)

Description:

Integrated BioTherapeutics is a biotechnology company that focuses on discovering novel vaccines and therapeutics for emerging infectious diseases. Its antiviral pipeline includes unique pan-filovirus antibody candidates, vaccines, and a variety of other product candidates for emerging viruses.

Total Funding Amount:

$9.37M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Rockville, Maryland, United States

Founded Date:

2005-01-01

Founders:

M. Javad Aman

Number of Employees:

11-50

Last Funding Date:

2023-05-10

IPO Status:

Private

Industries:

© 2025 bioDAO.ai